About
Stella Paffenholz is a senior associate at Atlas Venture, where she builds and invests in early-stage companies developing therapies from novel biology. She was previously a principal on the investment team at Nextech Invest, investing from Series A through public markets, and earlier held roles at McKinsey & Company, Apollo Health Ventures, and Merck KGaA. She holds a PhD from Memorial Sloan Kettering Cancer Center, where she studied genetic determinants of cancer treatment response, along with an MS from the German Cancer Research Center/University of Heidelberg and a BS from the University of Bonn.
Invests in
Biotech
Experience
- Atlas VentureSenior Associatecurrent2026 — present
- Multiple Myeloma Research Foundation - MMRFIndependent Investment Committee Membercurrent2026 — present
- Memorial Sloan Kettering Cancer CenterEntrepreneur in Residence & Advisorcurrent2025 — present
- NucleateAdvisorcurrent2023 — present
- Sesame TherapeuticsBoard Observer2025 — 2026
- Nextech InvestPrincipal2025 — 2026Boston, Massachusetts, United States
- Nextech InvestAssociate2023 — 2025Boston, Massachusetts, United States
- Nextech InvestVenture Fellow (full-time)2022 — 2023Boston, Massachusetts, United States
- Be BiopharmaBoard Observer2025 — 2026
- Flare TherapeuticsBoard Observer2024 — 2026
- Tubulis GmbHBoard Observer2024 — 2026
- Delphia TherapeuticsBoard Observer2023 — 2026Boston, Massachusetts, United States
- Mariana OncologyBoard Observer2023 — 2024
- Homeward Bound ProjectsHomeward Bound Team HB72022 — 2023
- Included VCVenture Capital Fellow (Class '22)2022
- Apollo Health VenturesVenture Developer2022
- Memorial Sloan Kettering Cancer CenterPh.D. Student2017 — 2022New York City Metropolitan Area
- Memorial Sloan Kettering Cancer CenterGraduate Teaching Assistant2019 — 2020
- Memorial Sloan Kettering Cancer CenterCo-Chair GSK Women in Science2017 — 2019
- Tri-Institutional Biotech ClubPresident2021 — 2022New York, United States
- Tri-Institutional Biotech ClubDirector Of External Affairs2019 — 2021
- Tri-Institutional Biotech ClubDirector of Finance2018 — 2019Großraum New York City und Umgebung
- McKinsey & CompanyAssociate Intern2022Frankfurt am Main, Hesse, Germany
- European Forum AlpbachScholarship Recipient2020Virtual
- Mount Sinai Innovation PartnersInnovation Fellow2019 — 2020
- Merck KGaA, Darmstadt, GermanyMerck Innovation Cup 20192019Darmstadt, Hesse, Germany
- Lindau Nobel Laureate MeetingsYoung Scientist2018Lindau
- Merck KGaA, Darmstadt, GermanyIntern in Inhouse Consulting2016Darmstadt, Hesse, Germany
- DKFZ German Cancer Research CenterResearch Associate2016Dr. Michael Milsom and Prof. Andreas Trumpp, Division of Stem Cells and Cancer
- DKFZ German Cancer Research CenterMaster Thesis Student2015Dr. Michael Milsom and Prof. Andreas Trumpp, Division of Stem Cells and Cancer
- St. Peter ZülpichOrganist and Church Choir Leader2008 — 2015Zülpich, North Rhine-Westphalia, Germany
- Whitehead InstituteResearch Intern2015Prof. Robert A. Weinberg, Biology Department
- Harvard Medical SchoolResearch Intern2014Prof. Pier Paolo Pandolfi, Division of Genetics
- LIMES (Life and Medical Sciences) InstituteBachelor Thesis Student2013Prof. Günter Mayer, Department of Chemical Biology
- Bayer HealthCareResearch Intern2012Lead Discovery Biochemistry / HTS Technology
- Weizmann Institute of ScienceSummer Research Intern2010Prof. Adi Kimchi, Department of Molecular Genetics
- LIMES (Life and Medical Sciences) InstituteResearch Intern2010Prof. Michael Hoch, Department of Molecular Developmental Biology
Skills & more
+12 more
Due DiligenceProject ManagementData AnalysisPresentation SkillsCell BiologyWestern BlotCell CultureMolecular BiologyFlow CytometryCancer BiologyGenome EditingMicrosoft PowerPointLanguages Englisch · French · German · Latin
- VC University — VC University
- Included VC Fellowship (2022) — Included VC
- Beginner to Pro in Excel: Financial Modeling and Valuation — Udemy
- AI For Everyone — DeepLearning.AI
- Problem Solving with Excel — PwC
- Business Strategy Specialization — University of Virginia Darden School of Business
- Financial Markets (with Honors) — Coursera
- Introduction to Project Management — edX
- Business Concepts for Life Scientists — Science Communication Lab
- Responsible Conduct of Research — Memorial Sloan Kettering Cancer Center
From Stella's professional profile.
Investments
Board seats
Delphia TherapeuticsTubulis
Per the firm's website.
Colleagues at Atlas Venture
Frequently asked questions
- Who is Stella Paffenholz?
- Stella Paffenholz is a senior associate at Atlas Venture, where she builds and invests in early-stage companies developing therapies from novel biology. She was previously a principal on the investment team at Nextech Invest, investing from Series A through public markets, and earlier held roles at McKinsey & Company, Apollo Health Ventures, and Merck KGaA. She holds a PhD from Memorial Sloan Kettering Cancer Center, where she studied genetic determinants of cancer treatment response, along with an MS from the German Cancer Research Center/University of Heidelberg and a BS from the University of Bonn.
- Where does Stella Paffenholz work?
- Stella Paffenholz is Senior Associate at Atlas Venture.
- What does Stella Paffenholz invest in?
- Stella Paffenholz invests in Biotech.
- What boards does Stella Paffenholz sit on?
- Stella Paffenholz holds tracked board seats at Delphia Therapeutics, Tubulis.
- Where did Stella Paffenholz go to school?
- Stella Paffenholz studied at Gerstner Sloan Kettering Graduate School of Biomedical Sciences at Memorial Sloan Kettering Cancer Center (Doctor of Philosophy - PhD, Cancer Biology); Weill Cornell Graduate School of Medical Sciences (Drug Development Course - From Molecule to Prescription); Cold Spring Harbor Laboratory (Programming for Biology).
Same school
Also attended Weill Cornell Graduate School of Medical Sciences16
+ 10 more
Also attended Cold Spring Harbor Laboratory6
Also attended Heidelberg University70
+ 64 more
Also attended The University of Bonn46
+ 40 more
Shared employers
Also worked at Nextech Invest9
+ 3 more
Also worked at Delphia Therapeutics1
Also worked at McKinsey & Company1,994
+ 1,988 more
Also worked at Merck KGaA, Darmstadt, Germany18
+ 12 more














































%20(2).png)


















